Half of Koreans who changed medication on AI advice had side effects, survey finds

Nov 19, 2026
The Korea Consumer Agency also found ChatGPT and Perplexity pointed users to sites selling drugs banned from online sale.

More than half of people in South Korea who stopped or changed their medication based on answers from generative AI chatbots reported negative health effects, according to a survey by the Korea Consumer Agency.

The agency surveyed 500 adults who had used AI to buy or take medicine or health supplements in the past year. Of them, 110 said they had stopped or changed medication on their own based on AI information, and 56 of those, or 50.9%, had side effects. Mild reactions such as heartburn were most common, 19.1% saw setbacks in their treatment and 14.5% had serious reactions needing more treatment. A further 26.6% of all respondents said they had put off or skipped a hospital visit because they trusted the AI's information.

The agency also tested how OpenAI's ChatGPT, Google's Gemini, Anthropic's Claude and Perplexity answer questions about medicines. ChatGPT and Perplexity gave medicine information based on symptoms alone, without checking age, existing conditions or other medications. Asked how to buy medicines banned from online sale, ChatGPT and Perplexity pointed to proxy-purchase websites all three times, Claude once in three and Gemini never. All four showed warnings, but these were often hard to notice.

The agency urged AI companies to strengthen warnings and block guidance to sites that sell drugs illegally. OpenAI and Anthropic said they would consider strengthening filtering and warnings, Google said it would keep its current notices and Perplexity did not respond, according to Korea JoongAng Daily.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more
Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.